Non-invasive Hemoglobin Monitoring in Outpatient Total Joint Arthroplasty

Accuracy of Non-invasive Hemoglobin Monitoring in Patients Undergoing Outpatient Total Joint Arthroplasty

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT05369325

Enrollment

200

Registered

2022-05-11

Start date

2022-06-15

Completion date

2023-07-01

Last updated

2023-07-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Total Joint Arthroplasty

Brief summary

This research is being done to better understand the accuracy of noninvasive hemoglobin tests on patients that recently underwent total joint arthroplasty.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Yes

Inclusion criteria

* Adult patients age ≥ 18. * Undergoing either primary total knee or total hip arthroplasty for a primary underlying diagnosis of osteoarthritis.

Exclusion criteria

\- Individuals \< 18 years of age.

Design outcomes

Primary

Measure	Time frame	Description
Concordance between non-invasive Hgb and serum Hgb	1 hour	How closely the non-invasive and serum Hgbs correlate with one another statistically
Patient satisfaction with non-invasive Hgb	1 day	Patients will get a survey to fill out following the Hgb measurements that assesses their satisfaction with the non-invasive method
Nurse satisfaction with non-invasive Hgb	1 day	Nurses will get a survey to fill out following the Hgb measurements that assesses their satisfaction with the non-invasive method
Cost comparison between non-invasive and serum Hgb	1 year	We will analyze cost differences between the non-invasive Hgb devices and the serum lab tests

Countries

United States

Outcome results